Brief: Abvc Biopharma Says Nasdaq Granted Co An Extension To Comply With A Listing Rule
14/07/2023 22:28
July 14 (Reuters) - ABVC Biopharma Inc ABVC.O :
* ABVC BIOPHARMA - ON JULY 10, NASDAQ GRANTED CO AN
EXTENSION TO
COMPLY WITH LISTING RULE 5550(B)(1)
* ABVC BIOPHARMA INC - MUST NOW ACHIEVE COMPLIANCE WITH
LISTING
RULE 5550(B)(1) ON OR BEFORE AUGUST 31, 2023
Further company coverage: ABVC.O
Recent news on ABVC Biopharma
See all newsBrief: ABVC Biopharma - Quarterly Period Ended September, 2025 Financial Statements Should Not Be Relied Upon
Brief: Abvc Biopharma Inc Files For Mixed Shelf Of Up To $100 Million - SEC Filing
Brief: ABVC Biopharma Concluded That Financial Statements For FY Ended Dec 31, 2023 Should No Longer Be Relied Upon Due To Errors In Financial Statements
Brief: ABVC Biopharma Inc On March 5, Leeds Chow Resigns As CFO Of Abvc Biopharma
Brief: ABVC Biopharma Secures $200,000 In First Cash Licensing Payment From Oncology Products Partner